The effects of active nutritional support to patients with head and neck cancer during concurrent chemoradiotherapy
Not Applicable
- Conditions
- head and neck cancer(nasopharyngeal carcinoma, oropharyngeal carcinoma, hypopharyngeal carcinoma, supraglottic laryngeal carcinoma, cancers of the oral cavity)
- Registration Number
- JPRN-UMIN000004738
- Lead Sponsor
- Osaka Medical Center for Cancer and Cardiovascular Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with ileus 2)Patients with no residual intestinal function 3)Patients with severe liver disorder or renal disorder 4)Patients with abnormal glucose metabolism such as severe diabetes mellitus : HbA1c > 7.0% 5)Patients with congenital disorders of amino acid metabolism 6)Patients with allergy to any ingredient of milk 7)Patients with electrolyte metabolism 8)Patients with hemophilia 9)Patients who were given a blood transfusion within 1 month 10)Pregnant women, women suspected of being pregnant, or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent change of body weight loss during chemoradiotherapy
- Secondary Outcome Measures
Name Time Method 1)Physical examination, blood test 2)immune status index 3)treatment completion rate 4)occurrence of adverse events